• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5074679)   Today's Articles (206)
For: Walsh M, Jayne D. Targeting the B cell in vasculitis. Pediatr Nephrol 2009;24:1267-75. [PMID: 18931860 DOI: 10.1007/s00467-008-1010-z] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2008] [Revised: 07/17/2008] [Accepted: 07/21/2008] [Indexed: 01/19/2023]
Number Cited by Other Article(s)
1
Ndayambaje M, Wahnou H, Sow M, Chgari O, Habyarimana T, Karkouri M, Limami Y, Naya A, Oudghiri M. Exploring the multifaceted effects of Ammi visnaga: subchronic toxicity, antioxidant capacity, immunomodulatory, and anti-inflammatory activities. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART A 2024;87:150-165. [PMID: 38037686 DOI: 10.1080/15287394.2023.2289430] [Citation(s) in RCA: 11] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/02/2023]
2
Rituximab as maintenance therapy for ANCA associated vasculitis: how, when and why? ACTA ACUST UNITED AC 2015;12:39-46. [PMID: 26255570 DOI: 10.1016/j.reuma.2015.06.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2015] [Revised: 06/02/2015] [Accepted: 06/07/2015] [Indexed: 12/27/2022]
3
Marinaki S, Skalioti C, Boletis JN. B cell depletion: rituximab in glomerular disease and transplantation. NEPHRON EXTRA 2013;3:125-30. [PMID: 24550930 PMCID: PMC3919423 DOI: 10.1159/000356050] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
4
Marinaki S, Kolovou K, Boletis JN. A male patient with diabetes and bilateral leg swelling. NEPHRON. CLINICAL PRACTICE 2013;121:c151-c158. [PMID: 23327808 DOI: 10.1159/000342651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
5
Alba MA, Flores-Suárez LF. [Rituximab for the treatment of ANCA associated vasculitis: the future today?]. ACTA ACUST UNITED AC 2011;7 Suppl 3:S41-6. [PMID: 22115869 DOI: 10.1016/j.reuma.2011.10.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2011] [Accepted: 10/05/2011] [Indexed: 11/26/2022]
6
Garcia-Valladares I, Espinoza LR. Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile? Curr Rheumatol Rep 2011;12:395-8. [PMID: 20844995 DOI: 10.1007/s11926-010-0133-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
7
Tadema H, Abdulahad WH, Lepse N, Stegeman CA, Kallenberg CGM, Heeringa P. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission. Rheumatology (Oxford) 2010;50:689-96. [PMID: 21149241 DOI: 10.1093/rheumatology/keq375] [Citation(s) in RCA: 56] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]  Open
8
Jayne D. Rituximab Treatment for Vasculitis. Clin J Am Soc Nephrol 2010;5:1359-62. [DOI: 10.2215/cjn.05500610] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
9
Vanoni F, Bettinelli A, Keller F, Bianchetti MG, Simonetti GD. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol 2010;25:205-12. [PMID: 19641940 DOI: 10.1007/s00467-009-1253-3] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/16/2009] [Revised: 06/14/2009] [Accepted: 06/15/2009] [Indexed: 01/17/2023]
10
LUI NL, THUMBOO J, FONG KY. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy. Int J Rheum Dis 2009;12:366-9. [DOI: 10.1111/j.1756-185x.2009.01438.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
11
Brunner J, Freund M, Prelog M, Binder E, Sailer-Hoeck M, Jungraithmayr T, Huemer C, Sergi C, Zimmerhackl LB. Successful treatment of severe juvenile microscopic polyangiitis with rituximab. Clin Rheumatol 2009;28:997-999. [PMID: 19390907 DOI: 10.1007/s10067-009-1177-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2009] [Accepted: 03/27/2009] [Indexed: 01/19/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA